Contract development and manufacturing (CDMO) for Pharmaceutical, Nutraceutical and CBD Products

The company is a contract development and manufacturing organization (CDMO) for Pharmaceutical, Nutraceutical and CBD Products worldwide.  The company's niche in this growing CDMO market has been as a full-service provider focused on 505B2 drugs candidates.  However, the business model shifted in the past couple of years to accommodate Nutraceutical and CBD products contract development and manufacturing activities.  Their contract research and manufacturing business is focused on Gum delivery technology, orally disintegrating tablets (ODT), capsules, conventional tableting and taste masking, using a chewing gum patented technology.

Advantages:

The company is working towards a defensible, approved and competitive technology position for oral delivery of targeted blockbuster pharmaceutical products whose patents will expire soon.

The company is equipped with chewing gum, tablet, capsule, liquid, semi-solid, gummy bears, packaging equipment and more.  With existing equipment, the company can produce R&D, pilot and production size of manufacturing.  

Potential Business Partners: Looking for agents and clients.